Armata Pharmaceuticals Stock (AMEX: ARMP)

Armata Pharmaceuticals

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ABVC

ACGN

APPH

ARMP

AURC

AWIN

CTCX

TSX:DXF

EEFT

FFIC

GOOGL

HCSG

INPX

LGHL

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MKFG

MMSI

MSFT

NLSP

NVTA

OPRA

PACW

SAGE

SASI

SIMO

SLAB

SLGN

SLNH

SNAP

SPWR

TDOC

TENB

TLRY

USNA

VICR

WORX

XPEV

YOSH

Gainers


	Silicon Motion Technology Corporation  (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company&#39;s Maxlinear merger.


Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

APLD

BBIG

BCDA

BGLC

BMEA

CTGO

DFLI

DRIO

DWAC

EDUC

FUBO

GFAI

INFI

INVO

JAGX

KOSS

KSCP

LQDA

MRKR

PSQH

PXMD

QNCX

RYAAY

SDPI

STKH

STOK

VRAY

VRCA

XXII

YELL

ZVSA

Gainers


	Tupperware Brands Corporation  (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.


Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Monday.

Following the market opening Monday, the Dow traded up 0.46% to 35,391.23 while the NASDAQ rose 0.33% to 14,079.09. The S&amp;P 500, also rose, gaining, 0.43% to 4,555.71.

Dow Surges 150 Points; Domino&#39;s Pizza Earnings Top Expectations

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals Inc

Press Releases

Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Armata Pharmaceuticals Announces Structural Biology Publication

Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia

Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update

Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting

Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 7th Annual Bacteriophage Therapy Summit

Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update

Armata Pharmaceuticals Receives $4.65 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02

INVA

Adicet Bio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Avalo Therapeutics

Cabaletta Bio

CytomX Therapeutics

Citius Oncology

Cue Biopharma

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Gain Therapeutics

Immix Biopharma

IO Biotech

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Kronos Bio

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

OKYO Pharma

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PepGen

PMV Pharma

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Renovaro

Repare Therapeutics

Serina Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

HC Wainwright & Co.

Axovant Gene Therapies Ltd. - Common Shares

Comments

Armata Pharmaceuticals

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell